英诺维瓦 INVA
$19.10 −$0.14 (-0.73%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $19.10 0.00%
开盘$19.54
昨收$19.24
当日区间$19.02 – $19.87
成交量1.65M
市值$1.36B
市盈率（TTM）8.1
股息率–
INVA 相关新闻
匹配 Innoviva 或代码 INVA 的头条新闻，按最新排序。
- Cantor Fitzgerald Maintains Innoviva(INVA.US) With Buy Rating, Raises Target Price to $34 正面
- BTIG Maintains Innoviva(INVA.US) With Buy Rating, Maintains Target Price $42
- Earnings Flash (INVA) Innoviva, Inc. Reports Q2 Revenue $119.6M, Vs. FactSet Est of $111.0M
- Cantor Fitzgerald Maintains Innoviva(INVA.US) With Buy Rating, Maintains Target Price $34
- H.C. Wainwright Maintains Innoviva(INVA.US) With Buy Rating, Maintains Target Price $46
- BTIG Maintains Innoviva(INVA.US) With Buy Rating, Raises Target Price to $42 正面
- Goldman Sachs Maintains Innoviva(INVA.US) With Sell Rating, Raises Target Price to $18 正面
- Analysts Offer Insights on Healthcare Companies: Spectral AI (MDAI), NeOnc Technologies Holdings, Inc. (NTHI) and Innoviva (INVA)
- Cantor Fitzgerald Maintains Innoviva(INVA.US) With Buy Rating, Maintains Target Price $32
- Cantor Fitzgerald Maintains Innoviva(INVA.US) With Buy Rating, Raises Target Price to $32 正面
- Oppenheimer Maintains Innoviva(INVA.US) With Buy Rating, Maintains Target Price $35
- BTIG Initiates Innoviva(INVA.US) With Buy Rating, Announces Target Price $35
- TR | OpenAI - 4o Maintains Innoviva(INVA.US) With Hold Rating, Raises Target Price to $21.5 正面
- H.C. Wainwright Maintains Innoviva(INVA.US) With Buy Rating, Raises Target Price to $45 正面
- Oppenheimer Initiates Innoviva(INVA.US) With Buy Rating, Announces Target Price $35
暂无评论——快来第一个聊聊 INVA。
登录后参与讨论。